Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L

Showing results (961-970 of 13,536) with videos related to

Pageof 1,354
Sort By:
Nucleic Acids Research|October 4, 2017
p53 regulates enhancer accessibility and activity in response to DNA damageScott T Younger, John L Rinn
Frontiers in Bioscience : a Journal and Virtual Library|November 29, 2002
Receptor protein tyrosine phosphatases as mediators of cellular adhesionPedro J Beltran, John L Bixby
Trends in Endocrinology and Metabolism: TEM|April 26, 2003
Insulin-like growth factor binding protein proteolysisR Clay Bunn, John L Fowlkes
The Journal of Allergy and Clinical Immunology|February 20, 2003
24. Clinical and laboratory assessment of immunityJames D Folds, John L Schmitz
Trends in Neurosciences|September 2, 2003
Forebrain gene expression domains and the evolving prosomeric modelLuis Puelles, John L R Rubenstein
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 17, 2002
Epinephrine inhibits insulin-stimulated muscle glucose transportDesmond G Hunt, John L Ivy
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2003
Greater effect of highly active antiretroviral therapy on survival in people aged > or =50 years compared with younger people in an urban observational cohortJohn L Perez, Richard D Moore
Expert Opinion on Pharmacotherapy|May 31, 2002
Capecitabine: fulfilling the promise of oral chemotherapyJimmy J Hwang, John L Marshall
The International Journal of Health Planning and Management|September 13, 2003
Privatization and the allure of franchising: a Zambian feasibility studyJohn L Fiedler, Jonathan B Wight
Dalton Transactions (Cambridge, England : 2003)|October 7, 2016
Transition metal complexes of the pyridylphosphine ligand o-C<sub>6</sub>H<sub>4</sub>(CH<sub>2</sub>PPy<sub>2</sub>)<sub>2</sub>Teresa F Vaughan, John L Spencer
Pageof 1,354

Showing results (961-970 of 13,536) with videos related to

Sort By:
Pageof 1,354
Nucleic Acids Research|October 4, 2017
p53 regulates enhancer accessibility and activity in response to DNA damageScott T Younger, John L Rinn
Frontiers in Bioscience : a Journal and Virtual Library|November 29, 2002
Receptor protein tyrosine phosphatases as mediators of cellular adhesionPedro J Beltran, John L Bixby
Trends in Endocrinology and Metabolism: TEM|April 26, 2003
Insulin-like growth factor binding protein proteolysisR Clay Bunn, John L Fowlkes
The Journal of Allergy and Clinical Immunology|February 20, 2003
24. Clinical and laboratory assessment of immunityJames D Folds, John L Schmitz
Trends in Neurosciences|September 2, 2003
Forebrain gene expression domains and the evolving prosomeric modelLuis Puelles, John L R Rubenstein
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 17, 2002
Epinephrine inhibits insulin-stimulated muscle glucose transportDesmond G Hunt, John L Ivy
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2003
Greater effect of highly active antiretroviral therapy on survival in people aged > or =50 years compared with younger people in an urban observational cohortJohn L Perez, Richard D Moore
Expert Opinion on Pharmacotherapy|May 31, 2002
Capecitabine: fulfilling the promise of oral chemotherapyJimmy J Hwang, John L Marshall
The International Journal of Health Planning and Management|September 13, 2003
Privatization and the allure of franchising: a Zambian feasibility studyJohn L Fiedler, Jonathan B Wight
Dalton Transactions (Cambridge, England : 2003)|October 7, 2016
Transition metal complexes of the pyridylphosphine ligand o-C<sub>6</sub>H<sub>4</sub>(CH<sub>2</sub>PPy<sub>2</sub>)<sub>2</sub>Teresa F Vaughan, John L Spencer
Pageof 1,354